Status:
UNKNOWN
Effects of Neuromuscular Electrical Stimulation on Individuals With Chronic Stroke in Patients With Chronic Stroke
Lead Sponsor:
Qassim University
Conditions:
Chronic Stroke
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Stroke is commonly associated with increased spasticity that affects patients' function and increased risk of fall. Interventional approaches have been used to decrease spasticity including pharmacolo...
Detailed Description
Assignment of intervention: Allocation sequence generation: The participants will be randomly allocated to either a EG or a NMESsham. The randomization process will be generated by an independent res...
Eligibility Criteria
Inclusion
- Hemiparesis due to stroke; at least 6 months since stroke
- Independent ambulatory ability with or without assistive device at least 10 meters
- Spasticity on ankle dorsiflexors ≥ 2 on Modified Ashworth Scale (MAS) (Charalambous, 2014)
- Functional ambulation ≥ 3 on functional ambulation categories (Mehrholz, Wagner, Rutte, Meiβner, \& Pohl, 2007)
Exclusion
- Skin integrity issues on contact surface of NMES
- Significant cognitive impairments (unable to follow 3 step commands),
- Other serious medical conditions
- History of other neurologic or orthopedic disorder affecting walking function
- More than one previous stroke
- Contraindications to NMES, such as a pacemaker or tumor
- Injected with any medicine that reduce spasticity
Key Trial Info
Start Date :
February 2 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04673045
Start Date
February 2 2021
End Date
June 1 2023
Last Update
September 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
King Fahad Specialist Hospital
Buraidah, Saudi Arabia